1 Study Coverage 1.1 Interleukin 1 Receptor Associated Kinase 4 Product Introduction 1.2 Market Segments 1.3 Key Interleukin 1 Receptor Associated Kinase 4 Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Interleukin 1 Receptor Associated Kinase 4 Market Size Growth Rate by Type 1.4.2 CA-4948 1.4.3 ND-2110 1.4.4 R-191 1.4.5 Others 1.5 Market by Application 1.5.1 Global Interleukin 1 Receptor Associated Kinase 4 Market Size Growth Rate by Application 1.5.2 Gouty Arthritis 1.5.3 Pasoriasis 1.5.4 Acute Myelocytic Leukemia 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Interleukin 1 Receptor Associated Kinase 4 Market Size, Estimates and Forecasts 2.1.1 Global Interleukin 1 Receptor Associated Kinase 4 Revenue 2015-2026 2.1.2 Global Interleukin 1 Receptor Associated Kinase 4 Sales 2015-2026 2.2 Global Interleukin 1 Receptor Associated Kinase 4, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.3 Interleukin 1 Receptor Associated Kinase 4 Historical Market Size by Region (2015-2020) 2.3.1 Global Interleukin 1 Receptor Associated Kinase 4 Retrospective Market Scenario in Sales by Region: 2015-2020 2.3.2 Global Interleukin 1 Receptor Associated Kinase 4 Retrospective Market Scenario in Revenue by Region: 2015-2020 2.4 Interleukin 1 Receptor Associated Kinase 4 Market Estimates and Projections by Region (2021-2026) 2.4.1 Global Interleukin 1 Receptor Associated Kinase 4 Sales Forecast by Region (2021-2026) 2.4.2 Global Interleukin 1 Receptor Associated Kinase 4 Revenue Forecast by Region (2021-2026) 3 Global Interleukin 1 Receptor Associated Kinase 4 Competitor Landscape by Players 3.1 Global Top Interleukin 1 Receptor Associated Kinase 4 Sales by Manufacturers 3.1.1 Global Interleukin 1 Receptor Associated Kinase 4 Sales by Manufacturers (2015-2020) 3.1.2 Global Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Manufacturers (2015-2020) 3.2 Global Interleukin 1 Receptor Associated Kinase 4 Manufacturers by Revenue 3.2.1 Global Interleukin 1 Receptor Associated Kinase 4 Revenue by Manufacturers (2015-2020) 3.2.2 Global Interleukin 1 Receptor Associated Kinase 4 Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Interleukin 1 Receptor Associated Kinase 4 Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Interleukin 1 Receptor Associated Kinase 4 Revenue in 2019 3.2.5 Global Interleukin 1 Receptor Associated Kinase 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Interleukin 1 Receptor Associated Kinase 4 Price by Manufacturers 3.4 Global Interleukin 1 Receptor Associated Kinase 4 Manufacturing Base Distribution, Product Types 3.4.1 Interleukin 1 Receptor Associated Kinase 4 Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Interleukin 1 Receptor Associated Kinase 4 Product Type 3.4.3 Date of International Manufacturers Enter into Interleukin 1 Receptor Associated Kinase 4 Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2015-2020) 4.1.1 Global Interleukin 1 Receptor Associated Kinase 4 Sales by Type (2015-2020) 4.1.2 Global Interleukin 1 Receptor Associated Kinase 4 Revenue by Type (2015-2020) 4.1.3 Interleukin 1 Receptor Associated Kinase 4 Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Interleukin 1 Receptor Associated Kinase 4 Market Size Forecast by Type (2021-2026) 4.2.1 Global Interleukin 1 Receptor Associated Kinase 4 Sales Forecast by Type (2021-2026) 4.2.2 Global Interleukin 1 Receptor Associated Kinase 4 Revenue Forecast by Type (2021-2026) 4.2.3 Interleukin 1 Receptor Associated Kinase 4 Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Interleukin 1 Receptor Associated Kinase 4 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2015-2020) 5.1.1 Global Interleukin 1 Receptor Associated Kinase 4 Sales by Application (2015-2020) 5.1.2 Global Interleukin 1 Receptor Associated Kinase 4 Revenue by Application (2015-2020) 5.1.3 Interleukin 1 Receptor Associated Kinase 4 Price by Application (2015-2020) 5.2 Interleukin 1 Receptor Associated Kinase 4 Market Size Forecast by Application (2021-2026) 5.2.1 Global Interleukin 1 Receptor Associated Kinase 4 Sales Forecast by Application (2021-2026) 5.2.2 Global Interleukin 1 Receptor Associated Kinase 4 Revenue Forecast by Application (2021-2026) 5.2.3 Global Interleukin 1 Receptor Associated Kinase 4 Price Forecast by Application (2021-2026) 6 Japan by Players, Type and Application 6.1 Japan Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth 2015-2026 6.1.1 Japan Interleukin 1 Receptor Associated Kinase 4 Sales YoY Growth 2015-2026 6.1.2 Japan Interleukin 1 Receptor Associated Kinase 4 Revenue YoY Growth 2015-2026 6.1.3 Japan Interleukin 1 Receptor Associated Kinase 4 Market Share in Global Market 2015-2026 6.2 Japan Interleukin 1 Receptor Associated Kinase 4 Market Size by Players (International and Local Players) 6.2.1 Japan Top Interleukin 1 Receptor Associated Kinase 4 Players by Sales (2015-2020) 6.2.2 Japan Top Interleukin 1 Receptor Associated Kinase 4 Players by Revenue (2015-2020) 6.3 Japan Interleukin 1 Receptor Associated Kinase 4 Historic Market Review by Type (2015-2020) 6.3.1 Japan Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Type (2015-2020) 6.3.2 Japan Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Type (2015-2020) 6.3.3 Japan Interleukin 1 Receptor Associated Kinase 4 Price by Type (2015-2020) 6.4 Japan Interleukin 1 Receptor Associated Kinase 4 Market Estimates and Forecasts by Type (2021-2026) 6.4.1 Japan Interleukin 1 Receptor Associated Kinase 4 Sales Forecast by Type (2021-2026) 6.4.2 Japan Interleukin 1 Receptor Associated Kinase 4 Revenue Forecast by Type (2021-2026) 6.4.3 Japan Interleukin 1 Receptor Associated Kinase 4 Price Forecast by Type (2021-2026) 6.5 Japan Interleukin 1 Receptor Associated Kinase 4 Historic Market Review by Application (2015-2020) 6.5.1 Japan Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Application (2015-2020) 6.5.2 Japan Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Application (2015-2020) 6.5.3 Japan Interleukin 1 Receptor Associated Kinase 4 Price by Application (2015-2020) 6.6 Japan Interleukin 1 Receptor Associated Kinase 4 Market Estimates and Forecasts by Application (2021-2026) 6.6.1 Japan Interleukin 1 Receptor Associated Kinase 4 Sales Forecast by Application (2021-2026) 6.6.2 Japan Interleukin 1 Receptor Associated Kinase 4 Revenue Forecast by Application (2021-2026) 6.6.3 Japan Interleukin 1 Receptor Associated Kinase 4 Price Forecast by Application (2021-2026) 7 North America 7.1 North America Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth 2015-2026 7.2 North America Interleukin 1 Receptor Associated Kinase 4 Market Facts & Figures by Country 7.2.1 North America Interleukin 1 Receptor Associated Kinase 4 Sales by Country (2015-2020) 7.2.2 North America Interleukin 1 Receptor Associated Kinase 4 Revenue by Country (2015-2020) 7.2.3 U.S. 7.2.4 Canada 8 Europe 8.1 Europe Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth 2015-2026 8.2 Europe Interleukin 1 Receptor Associated Kinase 4 Market Facts & Figures by Country 8.2.1 Europe Interleukin 1 Receptor Associated Kinase 4 Sales by Country 8.2.2 Europe Interleukin 1 Receptor Associated Kinase 4 Revenue by Country 8.2.3 Germany 8.2.4 France 8.2.5 U.K. 8.2.6 Italy 8.2.7 Russia 9 Asia Pacific 9.1 Asia Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth 2015-2026 9.2 Asia Pacific Interleukin 1 Receptor Associated Kinase 4 Market Facts & Figures by Country 9.2.1 Asia Pacific Interleukin 1 Receptor Associated Kinase 4 Sales by Region (2015-2020) 9.2.2 Asia Pacific Interleukin 1 Receptor Associated Kinase 4 Revenue by Region 9.2.3 China 9.2.4 Japan 9.2.5 South Korea 9.2.6 India 9.2.7 Australia 9.2.8 Taiwan 9.2.9 Indonesia 9.2.10 Thailand 9.2.11 Malaysia 9.2.12 Philippines 9.2.13 Vietnam 10 Latin America 10.1 Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth 2015-2026 10.2 Latin America Interleukin 1 Receptor Associated Kinase 4 Market Facts & Figures by Country 10.2.1 Latin America Interleukin 1 Receptor Associated Kinase 4 Sales by Country 10.2.2 Latin America Interleukin 1 Receptor Associated Kinase 4 Revenue by Country 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth 2015-2026 11.2 Middle East and Africa Interleukin 1 Receptor Associated Kinase 4 Market Facts & Figures by Country 11.2.1 Middle East and Africa Interleukin 1 Receptor Associated Kinase 4 Sales by Country 11.2.2 Middle East and Africa Interleukin 1 Receptor Associated Kinase 4 Revenue by Country 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Amgen Inc 12.1.1 Amgen Inc Corporation Information 12.1.2 Amgen Inc Description and Business Overview 12.1.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Amgen Inc Interleukin 1 Receptor Associated Kinase 4 Products Offered 12.1.5 Amgen Inc Recent Development 12.2 Astellas Pharma Inc 12.2.1 Astellas Pharma Inc Corporation Information 12.2.2 Astellas Pharma Inc Description and Business Overview 12.2.3 Astellas Pharma Inc Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Astellas Pharma Inc Interleukin 1 Receptor Associated Kinase 4 Products Offered 12.2.5 Astellas Pharma Inc Recent Development 12.3 Aurigene Discovery Technologies Ltd 12.3.1 Aurigene Discovery Technologies Ltd Corporation Information 12.3.2 Aurigene Discovery Technologies Ltd Description and Business Overview 12.3.3 Aurigene Discovery Technologies Ltd Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Aurigene Discovery Technologies Ltd Interleukin 1 Receptor Associated Kinase 4 Products Offered 12.3.5 Aurigene Discovery Technologies Ltd Recent Development 12.4 Beijing Hanmi Pharmaceutical Co Ltd 12.4.1 Beijing Hanmi Pharmaceutical Co Ltd Corporation Information 12.4.2 Beijing Hanmi Pharmaceutical Co Ltd Description and Business Overview 12.4.3 Beijing Hanmi Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Beijing Hanmi Pharmaceutical Co Ltd Interleukin 1 Receptor Associated Kinase 4 Products Offered 12.4.5 Beijing Hanmi Pharmaceutical Co Ltd Recent Development 12.5 Genentech Inc 12.5.1 Genentech Inc Corporation Information 12.5.2 Genentech Inc Description and Business Overview 12.5.3 Genentech Inc Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Genentech Inc Interleukin 1 Receptor Associated Kinase 4 Products Offered 12.5.5 Genentech Inc Recent Development 12.6 Merck & Co Inc 12.6.1 Merck & Co Inc Corporation Information 12.6.2 Merck & Co Inc Description and Business Overview 12.6.3 Merck & Co Inc Sales, Revenue and Gross Margin (2015-2020) 12.6.4 Merck & Co Inc Interleukin 1 Receptor Associated Kinase 4 Products Offered 12.6.5 Merck & Co Inc Recent Development 12.7 Rigel Pharmaceuticals Inc 12.7.1 Rigel Pharmaceuticals Inc Corporation Information 12.7.2 Rigel Pharmaceuticals Inc Description and Business Overview 12.7.3 Rigel Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020) 12.7.4 Rigel Pharmaceuticals Inc Interleukin 1 Receptor Associated Kinase 4 Products Offered 12.7.5 Rigel Pharmaceuticals Inc Recent Development 12.8 TG Therapeutics Inc 12.8.1 TG Therapeutics Inc Corporation Information 12.8.2 TG Therapeutics Inc Description and Business Overview 12.8.3 TG Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020) 12.8.4 TG Therapeutics Inc Interleukin 1 Receptor Associated Kinase 4 Products Offered 12.8.5 TG Therapeutics Inc Recent Development 12.11 Amgen Inc 12.11.1 Amgen Inc Corporation Information 12.11.2 Amgen Inc Description and Business Overview 12.11.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020) 12.11.4 Amgen Inc Interleukin 1 Receptor Associated Kinase 4 Products Offered 12.11.5 Amgen Inc Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter’s Five Forces Analysis 13.5 Primary Interviews with Key Interleukin 1 Receptor Associated Kinase 4 Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Interleukin 1 Receptor Associated Kinase 4 Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Interleukin 1 Receptor Associated Kinase 4 Market Segments Table 2. Ranking of Global Top Interleukin 1 Receptor Associated Kinase 4 Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Interleukin 1 Receptor Associated Kinase 4 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million) Table 4. Major Manufacturers of CA-4948 Table 5. Major Manufacturers of ND-2110 Table 6. Major Manufacturers of R-191 Table 7. Major Manufacturers of Others Table 8. Global Interleukin 1 Receptor Associated Kinase 4 Market Size Growth Rate by Application 2020-2026 (K Pcs) Table 9. Global Interleukin 1 Receptor Associated Kinase 4 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026 Table 10. Global Interleukin 1 Receptor Associated Kinase 4 Sales by Regions 2015-2020 (K Pcs) Table 11. Global Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Regions (2015-2020) Table 12. Global Interleukin 1 Receptor Associated Kinase 4 Revenue by Regions 2015-2020 (US$ Million) Table 13. Global Interleukin 1 Receptor Associated Kinase 4 Sales Forecast by Region (2021-2026) (K Pcs) Table 14. Global Interleukin 1 Receptor Associated Kinase 4 Sales by Manufacturers (2015-2020) (K Pcs) Table 15. Global Interleukin 1 Receptor Associated Kinase 4 Sales Share by Manufacturers (2015-2020) Table 16. Global Interleukin 1 Receptor Associated Kinase 4 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 17. Global Interleukin 1 Receptor Associated Kinase 4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interleukin 1 Receptor Associated Kinase 4 as of 2019) Table 18. Interleukin 1 Receptor Associated Kinase 4 Revenue by Manufacturers (2015-2020) (US$ Million) Table 19. Interleukin 1 Receptor Associated Kinase 4 Revenue Share by Manufacturers (2015-2020) Table 20. Key Manufacturers Interleukin 1 Receptor Associated Kinase 4 Price (2015-2020) (USD/Pcs) Table 21. Interleukin 1 Receptor Associated Kinase 4 Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Interleukin 1 Receptor Associated Kinase 4 Product Type Table 23. Date of International Manufacturers Enter into Interleukin 1 Receptor Associated Kinase 4 Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Interleukin 1 Receptor Associated Kinase 4 Sales by Type (2015-2020) (K Pcs) Table 26. Global Interleukin 1 Receptor Associated Kinase 4 Sales Share by Type (2015-2020) Table 27. Global Interleukin 1 Receptor Associated Kinase 4 Revenue by Type (2015-2020) (US$ Million) Table 28. Global Interleukin 1 Receptor Associated Kinase 4 Revenue Share by Type (2015-2020) Table 29. Interleukin 1 Receptor Associated Kinase 4 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs) Table 30. Global Interleukin 1 Receptor Associated Kinase 4 Sales Share by Type (2021-2026) Table 31. Global Interleukin 1 Receptor Associated Kinase 4 Sales by Application (2015-2020) (K Pcs) Table 32. Global Interleukin 1 Receptor Associated Kinase 4 Sales Share by Application (2015-2020) Table 33. Global Interleukin 1 Receptor Associated Kinase 4 Sales Share by Application (2021-2026) Table 34. Global Interleukin 1 Receptor Associated Kinase 4 Sales Market Share Forecast by Application (2021-2026) Table 35. Global Interleukin 1 Receptor Associated Kinase 4 Revenue by Application (2015-2020) (US$ Million) Table 36. Global Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share Forecast by Application (2021-2026) Table 37. Japan Interleukin 1 Receptor Associated Kinase 4 Sales (K Pcs) of Key Companies (2015-2020) Table 38. Japan Interleukin 1 Receptor Associated Kinase 4 Sales Share by Company (2015-2020) Table 39. Japan Interleukin 1 Receptor Associated Kinase 4 Revenue (US$ Million) by Company (2015-2020) Table 40. Japan Interleukin 1 Receptor Associated Kinase 4 Sales (K Pcs) by Type (2015-2020) Table 41. Japan Interleukin 1 Receptor Associated Kinase 4 Sales Share by Type (2015-2020) Table 42. Japan Interleukin 1 Receptor Associated Kinase 4 Revenue (US$ Million) Market Share by Type (2015-2020) Table 43. Japan Interleukin 1 Receptor Associated Kinase 4 Price (K Pcs) by Type (2015-2020) Table 44. Japan Interleukin 1 Receptor Associated Kinase 4 Sales (K Pcs) by Type (2021-2026) Table 45. Japan Interleukin 1 Receptor Associated Kinase 4 Sales Share by Type (2021-2026) Table 46. Japan Interleukin 1 Receptor Associated Kinase 4 Revenue (US$ Million) Market Share by Type (2021-2026) Table 47. Japan Interleukin 1 Receptor Associated Kinase 4 Revenue Share by Type (2021-2026) Table 48. Japan Interleukin 1 Receptor Associated Kinase 4 Price (K Pcs) by Type (2021-2026) Table 49. Japan Interleukin 1 Receptor Associated Kinase 4 Sales (K Pcs) by Application (2015-2020) Table 50. Japan Interleukin 1 Receptor Associated Kinase 4 Sales Share by Application (2015-2020) Table 51. Japan Interleukin 1 Receptor Associated Kinase 4 Revenue (US$ Million) Market Share by Application (2015-2020) Table 52. Japan Interleukin 1 Receptor Associated Kinase 4 Sales (K Pcs) by Application (2021-2026) Table 53. Japan Interleukin 1 Receptor Associated Kinase 4 Sales Share by Application (2021-2026) Table 54. Japan Interleukin 1 Receptor Associated Kinase 4 Revenue (US$ Million) Market Share by Application (2021-2026) Table 55. Japan Interleukin 1 Receptor Associated Kinase 4 Revenue Share by Application (2021-2026) Table 56. North America Interleukin 1 Receptor Associated Kinase 4 Sales by Country (2015-2020) (K Pcs) Table 57. North America Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Country (2015-2020) Table 58. North America Interleukin 1 Receptor Associated Kinase 4 Revenue by Country (2015-2020) (US$ Million) Table 59. North America Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Country (2015-2020) Table 60. Europe Interleukin 1 Receptor Associated Kinase 4 Sales by Country (2015-2020) (K Pcs) Table 61. Europe Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Country (2015-2020) Table 62. Europe Interleukin 1 Receptor Associated Kinase 4 Revenue by Country (2015-2020) (US$ Million) Table 63. Europe Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Country (2015-2020) Table 64. Asia Pacific Interleukin 1 Receptor Associated Kinase 4 Sales by Region (2015-2020) (K Pcs) Table 65. Asia Pacific Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Region (2015-2020) Table 66. Asia Pacific Interleukin 1 Receptor Associated Kinase 4 Revenue by Region (2015-2020) (US$ Million) Table 67. Asia Pacific Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Region (2015-2020) Table 68. Latin America Interleukin 1 Receptor Associated Kinase 4 Sales by Country (2015-2020) (K Pcs) Table 69. Latin America Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Country (2015-2020) Table 70. Latin Americaa Interleukin 1 Receptor Associated Kinase 4 Revenue by Country (2015-2020) (US$ Million) Table 71. Latin America Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Country (2015-2020) Table 72. Middle East and Africa Interleukin 1 Receptor Associated Kinase 4 Sales by Country (2015-2020) (K Pcs) Table 73. Middle East and Africa Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Country (2015-2020) Table 74. Middle East and Africa Interleukin 1 Receptor Associated Kinase 4 Revenue by Country (2015-2020) (US$ Million) Table 75. Middle East and Africa Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Country (2015-2020) Table 76. Amgen Inc Corporation Information Table 77. Amgen Inc Description and Business Overview Table 78. Amgen Inc Interleukin 1 Receptor Associated Kinase 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 79. Amgen Inc Interleukin 1 Receptor Associated Kinase 4 Product Table 80. Amgen Inc Recent Development Table 81. Astellas Pharma Inc Corporation Information Table 82. Astellas Pharma Inc Description and Business Overview Table 83. Astellas Pharma Inc Interleukin 1 Receptor Associated Kinase 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 84. Astellas Pharma Inc Product Table 85. Astellas Pharma Inc Recent Development Table 86. Aurigene Discovery Technologies Ltd Corporation Information Table 87. Aurigene Discovery Technologies Ltd Description and Business Overview Table 88. Aurigene Discovery Technologies Ltd Interleukin 1 Receptor Associated Kinase 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 89. Aurigene Discovery Technologies Ltd Product Table 90. Aurigene Discovery Technologies Ltd Recent Development Table 91. Beijing Hanmi Pharmaceutical Co Ltd Corporation Information Table 92. Beijing Hanmi Pharmaceutical Co Ltd Description and Business Overview Table 93. Beijing Hanmi Pharmaceutical Co Ltd Interleukin 1 Receptor Associated Kinase 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 94. Beijing Hanmi Pharmaceutical Co Ltd Product Table 95. Beijing Hanmi Pharmaceutical Co Ltd Recent Development Table 96. Genentech Inc Corporation Information Table 97. Genentech Inc Description and Business Overview Table 98. Genentech Inc Interleukin 1 Receptor Associated Kinase 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 99. Genentech Inc Product Table 100. Genentech Inc Recent Development Table 101. Merck & Co Inc Corporation Information Table 102. Merck & Co Inc Description and Business Overview Table 103. Merck & Co Inc Interleukin 1 Receptor Associated Kinase 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 104. Merck & Co Inc Product Table 105. Merck & Co Inc Recent Development Table 106. Rigel Pharmaceuticals Inc Corporation Information Table 107. Rigel Pharmaceuticals Inc Description and Business Overview Table 108. Rigel Pharmaceuticals Inc Interleukin 1 Receptor Associated Kinase 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 109. Rigel Pharmaceuticals Inc Product Table 110. Rigel Pharmaceuticals Inc Recent Development Table 111. TG Therapeutics Inc Corporation Information Table 112. TG Therapeutics Inc Description and Business Overview Table 113. TG Therapeutics Inc Interleukin 1 Receptor Associated Kinase 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 114. TG Therapeutics Inc Product Table 115. TG Therapeutics Inc Recent Development Table 116. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 117. Key Challenges Table 118. Market Risks Table 119. Main Points Interviewed from Key Interleukin 1 Receptor Associated Kinase 4 Players Table 120. Interleukin 1 Receptor Associated Kinase 4 Customers List Table 121. Interleukin 1 Receptor Associated Kinase 4 Distributors List Table 122. Research Programs/Design for This Report Table 123. Key Data Information from Secondary Sources Table 124. Key Data Information from Primary Sources List of Figures Figure 1. Interleukin 1 Receptor Associated Kinase 4 Product Picture Figure 2. Global Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Type in 2020 & 2026 Figure 3. CA-4948 Product Picture Figure 4. ND-2110 Product Picture Figure 5. R-191 Product Picture Figure 6. Others Product Picture Figure 7. Global Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Application in 2020 & 2026 Figure 8. Gouty Arthritis Figure 9. Pasoriasis Figure 10. Acute Myelocytic Leukemia Figure 11. Others Figure 12. Interleukin 1 Receptor Associated Kinase 4 Report Years Considered Figure 13. Global Interleukin 1 Receptor Associated Kinase 4 Market Size 2015-2026 (US$ Million) Figure 14. Global Interleukin 1 Receptor Associated Kinase 4 Sales 2015-2026 (K Pcs) Figure 15. Global Interleukin 1 Receptor Associated Kinase 4 Market Size Market Share by Region: 2020 Versus 2026 Figure 16. Global Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Region (2015-2020) Figure 17. Global Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Region in 2019 Figure 18. Global Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Region (2015-2020) Figure 19. Global Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Region in 2019 Figure 20. Global Interleukin 1 Receptor Associated Kinase 4 Sales Share by Manufacturer in 2019 Figure 21. The Top 10 and 5 Players Market Share by Interleukin 1 Receptor Associated Kinase 4 Revenue in 2019 Figure 22. Interleukin 1 Receptor Associated Kinase 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 23. Global Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Type (2015-2020) Figure 24. Global Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Type in 2019 Figure 25. Global Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Type (2015-2020) Figure 26. Global Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Type in 2019 Figure 27. Global Interleukin 1 Receptor Associated Kinase 4 Market Share by Price Range (2015-2020) Figure 28. Global Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Application (2015-2020) Figure 29. Global Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Application in 2019 Figure 30. Global Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Application (2015-2020) Figure 31. Global Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Application in 2019 Figure 32. Japan Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate 2015-2026 (K Pcs) Figure 33. Japan Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate 2015-2026 (US$ Million) Figure 34. Japan Interleukin 1 Receptor Associated Kinase 4 Market Share in Global Market 2015-2026 Figure 35. Japan 5 and 10 Largest Interleukin 1 Receptor Associated Kinase 4 Players Market Share by Revenue in Interleukin 1 Receptor Associated Kinase 4 in 2019 Figure 36. Japan Interleukin 1 Receptor Associated Kinase 4 Revenue Share by Type (2015-2020) Figure 37. Japan Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate by Type in 2015 & 2019 Figure 38. Japan Interleukin 1 Receptor Associated Kinase 4 Revenue Share by Application (2015-2020) Figure 39. Japan Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate by Application in 2015 & 2019 Figure 40. North America Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate 2015-2020 (K Pcs) Figure 41. North America Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate 2015-2020 (US$ Million) Figure 42. North America Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Country in 2019 Figure 43. North America Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Country in 2019 Figure 44. U.S. Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 45. U.S. Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. Canada Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 47. Canada Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Europe Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate 2015-2020 (K Pcs) Figure 49. Europe Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate 2015-2020 (US$ Million) Figure 50. Europe Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Country in 2019 Figure 51. Europe Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Country in 2019 Figure 52. Germany Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 53. Germany Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. France Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 55. France Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. U.K. Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 57. U.K. Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Italy Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 59. Italy Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Russia Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 61. Russia Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Asia Pacific Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate 2015-2020 (K Pcs) Figure 63. Asia Pacific Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate 2015-2020 (US$ Million) Figure 64. Asia Pacific Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Region in 2019 Figure 65. Asia Pacific Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Region in 2019 Figure 66. China Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 67. China Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Japan Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 69. Japan Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. South Korea Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 71. South Korea Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. India Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 73. India Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Australia Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 75. Australia Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Taiwan Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 77. Taiwan Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Indonesia Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 79. Indonesia Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Thailand Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 81. Thailand Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Malaysia Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 83. Malaysia Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 84. Philippines Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 85. Philippines Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 86. Vietnam Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 87. Vietnam Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 88. Latin America Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate 2015-2020 (K Pcs) Figure 89. Latin America Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate 2015-2020 (US$ Million) Figure 90. Latin America Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Country in 2019 Figure 91. Latin America Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Country in 2019 Figure 92. Mexico Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 93. Mexico Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 94. Brazil Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 95. Brazil Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 96. Argentina Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 97. Argentina Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 98. Middle East and Africa Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate 2015-2020 (K Pcs) Figure 99. Middle East and Africa Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate 2015-2020 (US$ Million) Figure 100. Middle East and Africa Interleukin 1 Receptor Associated Kinase 4 Sales Market Share by Country in 2019 Figure 101. Middle East and Africa Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Country in 2019 Figure 102. Turkey Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 103. Turkey Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 104. Saudi Arabia Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 105. Saudi Arabia Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 106. U.A.E Interleukin 1 Receptor Associated Kinase 4 Sales Growth Rate (2015-2020) (K Pcs) Figure 107. U.A.E Interleukin 1 Receptor Associated Kinase 4 Revenue Growth Rate (2015-2020) (US$ Million) Figure 108. Porter's Five Forces Analysis Figure 109. Interleukin 1 Receptor Associated Kinase 4 Value Chain Figure 110. Channels of Distribution Figure 111. Distributors Profiles Figure 112. Bottom-up and Top-down Approaches for This Report Figure 113. Data Triangulation Figure 114. Key Executives Interviewed

Amgen Inc Astellas Pharma Inc Aurigene Discovery Technologies Ltd Beijing Hanmi Pharmaceutical Co Ltd Genentech Inc Merck & Co Inc Rigel Pharmaceuticals Inc TG Therapeutics Inc